Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00038623
What this trial is testing

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00607724
What this trial is testing

GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Genentech, Inc. 68
Large-scale testing (Phase 3)Study completedNCT00002623
What this trial is testing

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 640
Not applicableLooking for participantsNCT05947838
What this trial is testing

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Who this might be right for
Appendiceal AdenocarcinomaColorectal
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238
What this trial is testing

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 42
Not applicableStudy completedNCT02206048
What this trial is testing

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

Who this might be right for
Cervix Carcinoma
M.D. Anderson Cancer Center 9
Large-scale testing (Phase 3)Study completedNCT01233843
What this trial is testing

Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

Who this might be right for
Squamous Cell Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 370
Testing effectiveness (Phase 2)UnknownNCT05840835
What this trial is testing

Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immix Biopharma, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Not applicableStudy completedNCT05380908
What this trial is testing

Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small-cell Lung Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 90
Testing effectiveness (Phase 2)Study completedNCT00412425
What this trial is testing

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 30
Early research (Phase 1)Looking for participantsNCT07501117
What this trial is testing

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Who this might be right for
Uveal Melanoma
Inge Marie Svane 15
Early research (Phase 1)Ended earlyNCT03894540
What this trial is testing

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor
Ipsen 22
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Testing effectiveness (Phase 2)Study completedNCT01152840
What this trial is testing

Study of RAD001 in Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic Carcinoma
Seoul National University Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT07471789
What this trial is testing

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Who this might be right for
Acute Myeloblastic LeukaemiaLeukemia, T-Cell
Gyala Therapeutics 33
Large-scale testing (Phase 3)Study completedNCT00003789
What this trial is testing

Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

Who this might be right for
Recurrent MelanomaStage III Melanoma
National Cancer Institute (NCI) 216
Large-scale testing (Phase 3)Looking for participantsNCT06200168
What this trial is testing

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
ElectroacupunctureOlanzapine-contained Four-drug AntiemeticNausea and Vomiting
Jiuda Zhao 370
Early research (Phase 1)Looking for participantsNCT06696768
What this trial is testing

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8+1 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT03050450
What this trial is testing

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Who this might be right for
Central Nervous System Tumors
Johns Hopkins All Children's Hospital 8
Next Page